文献速递冠心病外科

冠状动脉旁路移植联合骨髓干细胞移植:是否已成熟?

Combined Coronary Artery Bypass Surgery With Bone Marrow Stem Cell Transplantation: Are We There Yet?
PubMed 文献 · Ann Thorac Surg · 2019-08-06

该更新荟萃分析纳入13项随机对照试验,比较单纯CABG与CABG联合骨髓干细胞移植在4-6个月随访时的疗效。

要点

  • CABG联合BMSC移植可显著改善随访期左心室射血分数。
  • 瘢痕面积缩小和6分钟步行试验改善未达统计学显著性。
  • 注射BMSC数量或注射方式与射血分数变化无显著相关性。

核心结论

  • 现有证据表明CABG联合BMSC移植与左心室射血分数改善相关,但数据异质性提示患者反应存在差异,需进一步研究。

研究设计与样本

  • 更新荟萃分析,系统检索电子数据库纳入比较单纯CABG与CABG联合BMSC移植4-6个月随访结局的随机对照试验,采用随机效应模型,并行荟萃回归和亚组分析。

主要发现

  • 共纳入13项试验,BMSC组292例,CABG组247例。
  • 注射BMSC数量或注射方式与射血分数变化无显著相关性。

临床怎么用

  • 可将CABG联合BMSC移植视为改善左心室射血分数的潜在辅助策略,但需注意患者反应异质性,不宜常规推广。

局限性

  • 数据异质性显著(I2=74.2%),提示患者反应存在差异,需进一步研究理解变异来源。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Although the safety and feasibility of combined coronary artery bypass grafting (CABG) and bone marrow stem cell (BMSC) transplantation have been proven, the efficacy of this approach remains controversial. Therefore, we conducted an updated meta-analysis of randomized controlled trials to evaluate the efficacy of this procedure. METHODS: Electronic databases were systematically searched for randomized trials comparing 4-month to 6-month follow-up outcomes in patients who underwent isolated CABG (CABG group) and patients who received BMSC transplantation with CABG (BMSC group). A random-effects meta-analysis was conducted across eligible studies. Meta-regression and subgroup analyses were utilized to identify sources of data heterogeneity. RESULTS: Thirteen trials were eligible, with a total number of 292 patients in the BMSC group and 247 patients in the CABG group. Compared with the CABG group, the BMSC group showed significant improvement of follow-up left ventricular ejection fraction (n = 539, 4.8%; 95% confidence interval [CI], 2.3%-7.3%; P = .001). The analyzed data showed significant heterogeneity (I2 = 74.2%, P < .001). The reduction in scar size (n = 120; -2.2 mL; 95% CI, -18.2 mL to 13.7 mL; P = .44) and the improvement in the 6-minute walk test (n = 212; 41 m; 95% CI, -13 m to 95 m; P = .10) did not reach statistical significance. No significant correlation was found between the number of the injected BMSCs or the method of injection and the change in ejection fraction. CONCLUSIONS: The present evidence suggests that combined CABG and BMSC transplantation is associated with improvement of left ventricular ejection fraction. However, the heterogeneity in the data suggests variations in patient response to this therapy. Further studies are required to understand these variations.

来源:Ann Thorac Surg,查看原文。版权归原作者所有。

引用

  1. Ayyat KS, Argawi A, Mende M, et al. Combined Coronary Artery Bypass Surgery With Bone Marrow Stem Cell Transplantation: Are We There Yet? Ann Thorac Surg. 2019. PMID: 31398356. doi:10.1016/j.athoracsur.2019.05.094

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。